An Update on Pediatric Oncology and Hematology , An Issue of Hematology/Oncology Clinics of North America, 1st Edition
Author :
By Max J. Coppes, MD, PhD, MBA, Russell E. Ware, MD, PhD and Jeffrey S. Dome, MD, PhD
This issue highlights some of the exciting new developments in pediatric oncology and hematology. Three articles are devoted to pediatric leukemia, which remains the most common form of pediatric cancer. Specifically, articles address ALL, AML, and
...view more
This issue highlights some of the exciting new developments in pediatric oncology and hematology. Three articles are devoted to pediatric leukemia, which remains the most common form of pediatric cancer. Specifically, articles address ALL, AML, and leukemia in patients with Down syndrome. Other articles that address pediatric oncology include CNS tumors and neuroblastoma as well as advances in cancer immunotherapy. A very interesting article addresses the challenges experienced by adults who survived a childhood cancer. The hematology articles in this issue cover aspects that most clinicians see on a regular basis—sickle cell disease, thalassemia, and hemophilia, and ITP.
This issue highlights some of the exciting new developments in pediatric oncology and hematology. Three articles are devoted to pediatric leukemia, which remains the most common form of pediatric cancer. Specifically, articles address ALL, AML, and leukemia in patients with Down syndrome. Other articles that address pediatric oncology include CNS tumors and neuroblastoma as well as advances in cancer immunotherapy. A very interesting article addresses the challenges experienced by adults who survived a childhood cancer. The hematology articles in this issue cover aspects that most clinicians see on a regular basis—sickle cell disease, thalassemia, and hemophilia, and ITP.
Author Information
By Max J. Coppes, MD, PhD, MBA, Children's National Medical Center, Washington, DC; Russell E. Ware, MD, PhD, Director, Division of Hematology, Institute Co-Director, Cancer and Blood Diseases Institute, Associate Director, Global Health Center,Marjoy J. Johnson Chair of Hematology Translational Research, Cincinnati Children’s, Professor, UC Department of Pediatric,Cincinnati Ohio and Jeffrey S. Dome, MD, PhD
By Max J. Coppes, MD, PhD, MBA, Children's National Medical Center, Washington, DC; Russell E. Ware, MD, PhD, Director, Division of Hematology, Institute Co-Director, Cancer and Blood Diseases Institute, Associate Director, Global Health Center,Marjoy J. Johnson Chair of Hematology Translational Research, Cincinnati Children’s, Professor, UC Department of Pediatric,Cincinnati Ohio and Jeffrey S. Dome, MD, PhD
https://www.elsevierhealth.com.au/an-update-on-pediatric-oncology-and-hematology-an-issue-of-hematologyoncology-clinics-of-north-america-9781437722024.html299690An Update on Pediatric Oncology and Hematology , An Issue of Hematology/Oncology Clinics of North Americahttps://www.elsevierhealth.com.au/media/catalog/product/https://www.elsevierhealth.com.au/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.png122.96163.94AUDInStock/Clinics/Medicine & Surgery/Oncology/Medicine/Oncology/Clinics/Clinics/Medicine/Oncology/Japan Titles4388725433518050545855054666525504152598675263160This issue highlights some of the exciting new developments in pediatric oncology and hematology. Three articles are devoted to pediatric leukemia, which remains the most common form of pediatric cancer. Specifically, articles address ALL, AML, and leukemia in patients with Down syndrome. Other articles that address pediatric oncology include CNS tumors and neuroblastoma as well as advances in cancer immunotherapy. A very interesting article addresses the challenges experienced by adults who survived a childhood cancer. The hematology articles in this issue cover aspects that most clinicians see on a regular basis—sickle cell disease, thalassemia, and hemophilia, and ITP. This issue highlights some of the exciting new developments in pediatric oncology and hematology. Three articles are devoted to pediatric leukemia, which remains the most common form of pediatric cancer. Specifically, articles address ALL, AML, and leukemia in patients with Down syndrome. Other articles that address pediatric oncology include CNS tumors and neuroblastoma as well as advances in cancer immunotherapy. A very interesting article addresses the challenges experienced by adults who survived a childhood cancer. The hematology articles in this issue cover aspects that most clinicians see on a regular basis—sickle cell disease, thalassemia, and hemophilia, and ITP.00add-to-cart97814377220242011 and earlierProfessionalBy Max J. Coppes, MD, PhD, MBA, Russell E. Ware, MD, PhD and Jeffrey S. Dome, MD, PhD20101Book152w x 229hSaunders09 Mar 2010Please allow 7-10 working days for deliveryBy <STRONG>Max J. Coppes</STRONG>, MD, PhD, MBA, Children's National Medical Center, Washington, DC; <STRONG>Russell E. Ware</STRONG>, MD, PhD, Director, Division of Hematology, Institute Co-Director, Cancer and Blood Diseases Institute, Associate Director, Global Health Center,Marjoy J. Johnson Chair of Hematology Translational Research, Cincinnati Children’s, Professor, UC Department of Pediatric,Cincinnati Ohio and <STRONG>Jeffrey S. Dome</STRONG>, MD, PhDClinicsClinicsThe Clinics: Internal MedicineUnited StatesNoNoNoNoPlease SelectPlease SelectPlease Select
